In view of the clinical need for biomarkers that can be evaluated by IHC, we assessed the prognostic value of POSTN protein expression patterns in FFPE tumor samples from a cohort of 109 CMS-classified CRC patients (IHC cohort)37. This evidence concerns the gene POSTN and neoplasm.